ReP USP - Resultado da busca

Artigo de periodico
Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study (2024)
Pinto, Jairo Vinicius Merege de Mello Cruz; Crippa, José Alexandre de Souza ; Ceresér, Keila Maria; Vianna-Sulzbach, Miréia Fortes; Silveira Júnior, Érico de Moura; Rosa, Gabriel Santana da; Silva, Manoella Guatimuzim Testa da; Hizo, Gabriel Henrique; Medeiros, Leonardo Simão; Oliveira, Carlos Eduardo Santana de; Bristot, Giovana; Campos, Alline Cristina de ; Guimarães, Francisco Silveira ; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antônio Waldo ; Yatham, Lakshmi N.; Kapczinski, Flávio; Kauer-Sant’anna, Márcia
Source: The Canadian Journal of Psychiatry. Unidades: FMRP, ESALQ
Subjects: TRANSTORNO BIPOLAR, HUMOR, DEPRESSÃO, CANNABIS, CANABINOIDES, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Jairo Vinicius Merege de Mello Cruz et al. Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study. The Canadian Journal of Psychiatry, v. 69, n. 4, p. 242-251, 2024Tradução . . Disponível em: https://doi.org/10.1177/07067437231209650. Acesso em: 22 ago. 2024.
APA
Pinto, J. V. M. de M. C., Crippa, J. A. de S., Ceresér, K. M., Vianna-Sulzbach, M. F., Silveira Júnior, É. de M., Rosa, G. S. da, et al. (2024). Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study. The Canadian Journal of Psychiatry, 69( 4), 242-251. doi:10.1177/07067437231209650
NLM
Pinto JVM de MC, Crippa JA de S, Ceresér KM, Vianna-Sulzbach MF, Silveira Júnior É de M, Rosa GS da, Silva MGT da, Hizo GH, Medeiros LS, Oliveira CES de, Bristot G, Campos AC de, Guimarães FS, Hallak JEC, Zuardi AW, Yatham LN, Kapczinski F, Kauer-Sant’anna M. Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study [Internet]. The Canadian Journal of Psychiatry. 2024 ; 69( 4): 242-251.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1177/07067437231209650
Vancouver
Pinto JVM de MC, Crippa JA de S, Ceresér KM, Vianna-Sulzbach MF, Silveira Júnior É de M, Rosa GS da, Silva MGT da, Hizo GH, Medeiros LS, Oliveira CES de, Bristot G, Campos AC de, Guimarães FS, Hallak JEC, Zuardi AW, Yatham LN, Kapczinski F, Kauer-Sant’anna M. Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study [Internet]. The Canadian Journal of Psychiatry. 2024 ; 69( 4): 242-251.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1177/07067437231209650
Artigo de periodico-carta/editorial
Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial] (2023)
Crippa, José Alexandre de Souza ; Guimarães, Francisco Silveira ; Zuardi, Antônio Waldo ; Hallak, Jaime Eduardo Cecilio
Source: Brazilian Journal of Psychiatry. Unidade: FMRP
Subjects: CANABINOIDES, CANNABIS, ALUCINOGÊNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial]. Brazilian Journal of Psychiatry. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.47626/1516-4446-2023-0047. Acesso em: 22 ago. 2024. , 2023
APA
Crippa, J. A. de S., Guimarães, F. S., Zuardi, A. W., & Hallak, J. E. C. (2023). Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial]. Brazilian Journal of Psychiatry. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.47626/1516-4446-2023-0047
NLM
Crippa JA de S, Guimarães FS, Zuardi AW, Hallak JEC. Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial] [Internet]. Brazilian Journal of Psychiatry. 2023 ; 45( 3): 201-202.[citado 2024 ago. 22 ] Available from: https://doi.org/10.47626/1516-4446-2023-0047
Vancouver
Crippa JA de S, Guimarães FS, Zuardi AW, Hallak JEC. Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial] [Internet]. Brazilian Journal of Psychiatry. 2023 ; 45( 3): 201-202.[citado 2024 ago. 22 ] Available from: https://doi.org/10.47626/1516-4446-2023-0047
Artigo de periodico
Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats (2023)
Cardoso, Gleice Kelli Ribeiro da Silva ; Lopes, Willian Lazarini ; Primini, Eduardo Octaviano; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Zuardi, Antônio Waldo ; Garcia-Cairasco, Norberto ; Leite-Panissi, Christie Ramos Andrade
Source: Behavioural Brain Research. Unidades: FMRP, FFCLRP
Subjects: CANNABIS, DOR CRÔNICA, DOENÇAS DO SISTEMA NERVOSO PERIFÉRICO, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOSO, Gleice Kelli Ribeiro da Silva et al. Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats. Behavioural Brain Research, v. 452, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2023.114588. Acesso em: 22 ago. 2024.
APA
Cardoso, G. K. R. da S., Lopes, W. L., Primini, E. O., Hallak, J. E. C., Crippa, J. A. de S., Zuardi, A. W., et al. (2023). Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats. Behavioural Brain Research, 452, 1-16. doi:10.1016/j.bbr.2023.114588
NLM
Cardoso GKR da S, Lopes WL, Primini EO, Hallak JEC, Crippa JA de S, Zuardi AW, Garcia-Cairasco N, Leite-Panissi CRA. Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats [Internet]. Behavioural Brain Research. 2023 ; 452 1-16.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1016/j.bbr.2023.114588
Vancouver
Cardoso GKR da S, Lopes WL, Primini EO, Hallak JEC, Crippa JA de S, Zuardi AW, Garcia-Cairasco N, Leite-Panissi CRA. Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats [Internet]. Behavioural Brain Research. 2023 ; 452 1-16.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1016/j.bbr.2023.114588
Artigo de periodico
Systemic chronic treatment with cannabidiol in carioca high- and low-conditioned freezing rats in the neuropathic pain model: evaluation of pain sensitivity (2023)
Souza, Carolina Macêdo de; Maisonnette, Sílvia Soares; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Zuardi, Antônio Waldo ; Landeira-Fernandez, J.; Leite-Panissi, Christie Ramos Andrade
Source: Pharmaceuticals. Unidades: FMRP, FFCLRP
Subjects: CANABINOIDES, ANSIEDADE, DOR CRÔNICA, DOENÇAS DO SISTEMA NERVOSO PERIFÉRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Carolina Macêdo de et al. Systemic chronic treatment with cannabidiol in carioca high- and low-conditioned freezing rats in the neuropathic pain model: evaluation of pain sensitivity. Pharmaceuticals, v. 16, n. 7, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.3390/ph16071003. Acesso em: 22 ago. 2024.
APA
Souza, C. M. de, Maisonnette, S. S., Hallak, J. E. C., Crippa, J. A. de S., Zuardi, A. W., Landeira-Fernandez, J., & Leite-Panissi, C. R. A. (2023). Systemic chronic treatment with cannabidiol in carioca high- and low-conditioned freezing rats in the neuropathic pain model: evaluation of pain sensitivity. Pharmaceuticals, 16( 7), 1-15. doi:10.3390/ph16071003
NLM
Souza CM de, Maisonnette SS, Hallak JEC, Crippa JA de S, Zuardi AW, Landeira-Fernandez J, Leite-Panissi CRA. Systemic chronic treatment with cannabidiol in carioca high- and low-conditioned freezing rats in the neuropathic pain model: evaluation of pain sensitivity [Internet]. Pharmaceuticals. 2023 ; 16( 7): 1-15.[citado 2024 ago. 22 ] Available from: https://doi.org/10.3390/ph16071003
Vancouver
Souza CM de, Maisonnette SS, Hallak JEC, Crippa JA de S, Zuardi AW, Landeira-Fernandez J, Leite-Panissi CRA. Systemic chronic treatment with cannabidiol in carioca high- and low-conditioned freezing rats in the neuropathic pain model: evaluation of pain sensitivity [Internet]. Pharmaceuticals. 2023 ; 16( 7): 1-15.[citado 2024 ago. 22 ] Available from: https://doi.org/10.3390/ph16071003
Artigo de periodico
Mental health trajectories of Brazilian health workers during two waves of the COVID-19 pandemic (2020–2021) (2023)
Osório, Flávia de Lima ; Zuardi, Antônio Waldo ; Silveira, Isabella Lara Machado ; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Pereira-Lima, Karina ; Loureiro, Sonia Regina
Source: Frontiers in Psychiatry. Unidade: FMRP
Subjects: COVID-19, SAÚDE MENTAL, ANSIEDADE, ESTRESSE PROFISSIONAL, PROFISSIONAIS DA SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OSÓRIO, Flávia de Lima et al. Mental health trajectories of Brazilian health workers during two waves of the COVID-19 pandemic (2020–2021). Frontiers in Psychiatry, v. 14, p. 1-8, 2023Tradução . . Disponível em: https://doi.org/10.3389/fpsyt.2023.1026429. Acesso em: 22 ago. 2024.
APA
Osório, F. de L., Zuardi, A. W., Silveira, I. L. M., Crippa, J. A. de S., Hallak, J. E. C., Pereira-Lima, K., & Loureiro, S. R. (2023). Mental health trajectories of Brazilian health workers during two waves of the COVID-19 pandemic (2020–2021). Frontiers in Psychiatry, 14, 1-8. doi:10.3389/fpsyt.2023.1026429
NLM
Osório F de L, Zuardi AW, Silveira ILM, Crippa JA de S, Hallak JEC, Pereira-Lima K, Loureiro SR. Mental health trajectories of Brazilian health workers during two waves of the COVID-19 pandemic (2020–2021) [Internet]. Frontiers in Psychiatry. 2023 ; 14 1-8.[citado 2024 ago. 22 ] Available from: https://doi.org/10.3389/fpsyt.2023.1026429
Vancouver
Osório F de L, Zuardi AW, Silveira ILM, Crippa JA de S, Hallak JEC, Pereira-Lima K, Loureiro SR. Mental health trajectories of Brazilian health workers during two waves of the COVID-19 pandemic (2020–2021) [Internet]. Frontiers in Psychiatry. 2023 ; 14 1-8.[citado 2024 ago. 22 ] Available from: https://doi.org/10.3389/fpsyt.2023.1026429
Artigo de periodico
Progression of the COVID-19 pandemic, Brazilian healthcare workers’ emotional burden and the effects on professional fulfillment at the end of the third wave: a longitudinal study (2023)
Loureiro, Sonia Regina ; Zuardi, Antônio Waldo ; Silveira, Isabella Lara Machado ; Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Osório, Flávia de Lima
Source: Frontiers in Psychiatry. Unidade: FMRP
Subjects: SAÚDE MENTAL, OCUPAÇÕES EM SAÚDE, ESTUDOS LONGITUDINAIS, PANDEMIAS, COVID-19, ESTRESSE PROFISSIONAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOUREIRO, Sonia Regina et al. Progression of the COVID-19 pandemic, Brazilian healthcare workers’ emotional burden and the effects on professional fulfillment at the end of the third wave: a longitudinal study. Frontiers in Psychiatry, v. 14, p. 1-8, 2023Tradução . . Disponível em: https://doi.org/10.3389/fpsyt.2023.1237123. Acesso em: 22 ago. 2024.
APA
Loureiro, S. R., Zuardi, A. W., Silveira, I. L. M., Crippa, J. A. de S., Hallak, J. E. C., & Osório, F. de L. (2023). Progression of the COVID-19 pandemic, Brazilian healthcare workers’ emotional burden and the effects on professional fulfillment at the end of the third wave: a longitudinal study. Frontiers in Psychiatry, 14, 1-8. doi:10.3389/fpsyt.2023.1237123
NLM
Loureiro SR, Zuardi AW, Silveira ILM, Crippa JA de S, Hallak JEC, Osório F de L. Progression of the COVID-19 pandemic, Brazilian healthcare workers’ emotional burden and the effects on professional fulfillment at the end of the third wave: a longitudinal study [Internet]. Frontiers in Psychiatry. 2023 ; 14 1-8.[citado 2024 ago. 22 ] Available from: https://doi.org/10.3389/fpsyt.2023.1237123
Vancouver
Loureiro SR, Zuardi AW, Silveira ILM, Crippa JA de S, Hallak JEC, Osório F de L. Progression of the COVID-19 pandemic, Brazilian healthcare workers’ emotional burden and the effects on professional fulfillment at the end of the third wave: a longitudinal study [Internet]. Frontiers in Psychiatry. 2023 ; 14 1-8.[citado 2024 ago. 22 ] Available from: https://doi.org/10.3389/fpsyt.2023.1237123
Artigo de periodico-carta/editorial
Fifty years of research on cannabidiol as an anticonvulsant [Editorial]: the legacy of Brazilian groups (2023)
Zuardi, Antônio Waldo ; Crippa, José Alexandre de Souza
Source: Brazilian Journal of Psychiatry. Unidade: FMRP
Subjects: ANTICONVULSIVANTES, CANNABIS, CONVULSÕES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZUARDI, Antônio Waldo e CRIPPA, José Alexandre de Souza. Fifty years of research on cannabidiol as an anticonvulsant [Editorial]: the legacy of Brazilian groups. Brazilian Journal of Psychiatry. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.47626/1516-4446-2023-3377. Acesso em: 22 ago. 2024. , 2023
APA
Zuardi, A. W., & Crippa, J. A. de S. (2023). Fifty years of research on cannabidiol as an anticonvulsant [Editorial]: the legacy of Brazilian groups. Brazilian Journal of Psychiatry. São Paulo: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.47626/1516-4446-2023-3377
NLM
Zuardi AW, Crippa JA de S. Fifty years of research on cannabidiol as an anticonvulsant [Editorial]: the legacy of Brazilian groups [Internet]. Brazilian Journal of Psychiatry. 2023 ; 45( 6): 463-464.[citado 2024 ago. 22 ] Available from: https://doi.org/10.47626/1516-4446-2023-3377
Vancouver
Zuardi AW, Crippa JA de S. Fifty years of research on cannabidiol as an anticonvulsant [Editorial]: the legacy of Brazilian groups [Internet]. Brazilian Journal of Psychiatry. 2023 ; 45( 6): 463-464.[citado 2024 ago. 22 ] Available from: https://doi.org/10.47626/1516-4446-2023-3377
Artigo de periodico
Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022) (2022)
Souza, José Diogo Ribeiro de; Pacheco, Júlia Cozar; Rossi, Giordano Novak ; Paulo, Bruno O. de; Zuardi, Antônio Waldo ; Guimarães, Francisco Silveira ; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Santos, Rafael Guimarães dos
Source: Pharmaceutics. Unidade: FMRP
Subjects: CANABINOIDES, INTERAÇÃO DE MEDICAMENTOS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, José Diogo Ribeiro de et al. Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022). Pharmaceutics, v. 14, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14122598. Acesso em: 22 ago. 2024.
APA
Souza, J. D. R. de, Pacheco, J. C., Rossi, G. N., Paulo, B. O. de, Zuardi, A. W., Guimarães, F. S., et al. (2022). Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022). Pharmaceutics, 14, 1-14. doi:10.3390/pharmaceutics14122598
NLM
Souza JDR de, Pacheco JC, Rossi GN, Paulo BO de, Zuardi AW, Guimarães FS, Hallak JEC, Crippa JA de S, Santos RG dos. Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022) [Internet]. Pharmaceutics. 2022 ; 14 1-14.[citado 2024 ago. 22 ] Available from: https://doi.org/10.3390/pharmaceutics14122598
Vancouver
Souza JDR de, Pacheco JC, Rossi GN, Paulo BO de, Zuardi AW, Guimarães FS, Hallak JEC, Crippa JA de S, Santos RG dos. Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022) [Internet]. Pharmaceutics. 2022 ; 14 1-14.[citado 2024 ago. 22 ] Available from: https://doi.org/10.3390/pharmaceutics14122598
Artigo de periodico
Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes (2022)
Almeida, Valéria de; Seabra, Gabriela; Oliveira, Guilherme Reis de; Zuccoli, Giuliana S.; Rumin, Priscila; Fioramonte, Mariana; Smith, Bradley J.; Zuardi, Antônio Waldo ; Hallak, Jaime Eduardo Cecilio ; Campos, Alline Cristina de ; Crippa, José Alexandre de Souza ; Souza, Daniel Martins de
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FMRP
Subjects: CANABINOIDES, PROLIFERAÇÃO CELULAR, TRANSDUÇÃO DE SINAL CELULAR, PROTEÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Valéria de et al. Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes. European Archives of Psychiatry and Clinical Neuroscience, v. 272, n. 7, p. 1311-1323, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00406-022-01425-5. Acesso em: 22 ago. 2024.
APA
Almeida, V. de, Seabra, G., Oliveira, G. R. de, Zuccoli, G. S., Rumin, P., Fioramonte, M., et al. (2022). Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes. European Archives of Psychiatry and Clinical Neuroscience, 272( 7), 1311-1323. doi:10.1007/s00406-022-01425-5
NLM
Almeida V de, Seabra G, Oliveira GR de, Zuccoli GS, Rumin P, Fioramonte M, Smith BJ, Zuardi AW, Hallak JEC, Campos AC de, Crippa JA de S, Souza DM de. Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2022 ; 272( 7): 1311-1323.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1007/s00406-022-01425-5
Vancouver
Almeida V de, Seabra G, Oliveira GR de, Zuccoli GS, Rumin P, Fioramonte M, Smith BJ, Zuardi AW, Hallak JEC, Campos AC de, Crippa JA de S, Souza DM de. Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2022 ; 272( 7): 1311-1323.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1007/s00406-022-01425-5
Artigo de periodico
Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial (2022)
Crippa, José Alexandre de Souza ; Pacheco, Júlia Cozar; Zuardi, Antônio Waldo ; Guimarães, Francisco Silveira ; Campos, Alline Cristina de ; Osório, Flávia de Lima ; Loureiro, Sonia Regina ; Santos, Rafael Guimarães dos ; souza, José Diogo dos Santos; Ushirohira, Juliana Mayumi; Ferreira, Rafael Rinaldi; Costa, Karla Cristinne Mancini ; Scomparin, Davi Silveira; Scarante, Franciele Franco ; Santos, Isabela Pires dos; Mechoulam, Raphael; Kapczinski, Flávio; Fonseca, Benedito Antonio Lopes da ; Esposito, Danillo Lucas Alves ; Passos, Afonso Dinis Costa ; Dal-Fabbro, Amaury Lelis ; Bellissimo-Rodrigues, Fernando ; Arruda, Eurico ; Scarpelini, Sandro ; Andraus, Maristela Haddad; Nather Junior, Júlio Cesar; Wada, Danilo Tadao; Santos, Marcel Koenigkam ; Santos, Antonio Carlos dos ; Busatto Filho, Geraldo ; Hallak, Jaime Eduardo Cecilio
Source: Cannabis And Cannabinoid Research. Unidades: FMRP, FM
Subjects: COVID-19, CANABINOIDES, ENSAIO CLÍNICO, DOENÇAS INFECCIOSAS, MEDICINA INTERNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial. Cannabis And Cannabinoid Research, v. 7, n. 5, p. 658-669, 2022Tradução . . Disponível em: https://doi.org/10.1089/can.2021.0093. Acesso em: 22 ago. 2024.
APA
Crippa, J. A. de S., Pacheco, J. C., Zuardi, A. W., Guimarães, F. S., Campos, A. C. de, Osório, F. de L., et al. (2022). Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial. Cannabis And Cannabinoid Research, 7( 5), 658-669. doi:10.1089/can.2021.0093
NLM
Crippa JA de S, Pacheco JC, Zuardi AW, Guimarães FS, Campos AC de, Osório F de L, Loureiro SR, Santos RG dos, souza JD dos S, Ushirohira JM, Ferreira RR, Costa KCM, Scomparin DS, Scarante FF, Santos IP dos, Mechoulam R, Kapczinski F, Fonseca BAL da, Esposito DLA, Passos ADC, Dal-Fabbro AL, Bellissimo-Rodrigues F, Arruda E, Scarpelini S, Andraus MH, Nather Junior JC, Wada DT, Santos MK, Santos AC dos, Busatto Filho G, Hallak JEC. Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial [Internet]. Cannabis And Cannabinoid Research. 2022 ; 7( 5): 658-669.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1089/can.2021.0093
Vancouver
Crippa JA de S, Pacheco JC, Zuardi AW, Guimarães FS, Campos AC de, Osório F de L, Loureiro SR, Santos RG dos, souza JD dos S, Ushirohira JM, Ferreira RR, Costa KCM, Scomparin DS, Scarante FF, Santos IP dos, Mechoulam R, Kapczinski F, Fonseca BAL da, Esposito DLA, Passos ADC, Dal-Fabbro AL, Bellissimo-Rodrigues F, Arruda E, Scarpelini S, Andraus MH, Nather Junior JC, Wada DT, Santos MK, Santos AC dos, Busatto Filho G, Hallak JEC. Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial [Internet]. Cannabis And Cannabinoid Research. 2022 ; 7( 5): 658-669.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1089/can.2021.0093
Artigo de periodico
Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze (2022)
Fabris, Débora; Carvalho, Milene Cristina de ; Brandão, Marcus Lira ; Prado, Wiliam Alves do; Zuardi, Antônio Waldo ; Crippa, José Alexandre de Souza ; Oliveira, Amanda R. de; Lovick, Thelma A.; Genaro, Karina
Source: Journal of Psychopharmacology. Unidades: FMRP, FFCLRP
Subjects: ANSIEDADE, ANTIDEPRESSIVOS, FARMACOTERAPIA, CANABINOIDES, DIFERENÇAS SEXUAIS ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FABRIS, Débora et al. Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze. Journal of Psychopharmacology, v. 36, n. 12, p. 1371-1383, 2022Tradução . . Disponível em: https://doi.org/10.1177/02698811221125440. Acesso em: 22 ago. 2024.
APA
Fabris, D., Carvalho, M. C. de, Brandão, M. L., Prado, W. A. do, Zuardi, A. W., Crippa, J. A. de S., et al. (2022). Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze. Journal of Psychopharmacology, 36( 12), 1371-1383. doi:10.1177/02698811221125440
NLM
Fabris D, Carvalho MC de, Brandão ML, Prado WA do, Zuardi AW, Crippa JA de S, Oliveira AR de, Lovick TA, Genaro K. Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze [Internet]. Journal of Psychopharmacology. 2022 ; 36( 12): 1371-1383.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1177/02698811221125440
Vancouver
Fabris D, Carvalho MC de, Brandão ML, Prado WA do, Zuardi AW, Crippa JA de S, Oliveira AR de, Lovick TA, Genaro K. Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze [Internet]. Journal of Psychopharmacology. 2022 ; 36( 12): 1371-1383.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1177/02698811221125440
Artigo de periodico
Serotonin mediates the panicolytic-like effect of oxytocin in the dorsal periaqueductal gray (2020)
Sergio, Thatiane de Oliveira; Frias, Alana Tercino ; Vilela-Costa, Heloisa Helena; Oliveira, Danielle C. G. de; Zuardi, Antônio Waldo ; Zangrossi Junior, Hélio
Source: Journal of Psychopharmacology. Unidade: FMRP
Subjects: ANTIDEPRESSIVOS, ANSIEDADE, OCITOCINA, PÂNICO, RECEPTORES DE SEROTONINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SERGIO, Thatiane de Oliveira et al. Serotonin mediates the panicolytic-like effect of oxytocin in the dorsal periaqueductal gray. Journal of Psychopharmacology, v. 34, n. 4, p. 383-390, 2020Tradução . . Disponível em: https://doi.org/10.1177/0269881120907960. Acesso em: 22 ago. 2024.
APA
Sergio, T. de O., Frias, A. T., Vilela-Costa, H. H., Oliveira, D. C. G. de, Zuardi, A. W., & Zangrossi Junior, H. (2020). Serotonin mediates the panicolytic-like effect of oxytocin in the dorsal periaqueductal gray. Journal of Psychopharmacology, 34( 4), 383-390. doi:10.1177/0269881120907960
NLM
Sergio T de O, Frias AT, Vilela-Costa HH, Oliveira DCG de, Zuardi AW, Zangrossi Junior H. Serotonin mediates the panicolytic-like effect of oxytocin in the dorsal periaqueductal gray [Internet]. Journal of Psychopharmacology. 2020 ; 34( 4): 383-390.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1177/0269881120907960
Vancouver
Sergio T de O, Frias AT, Vilela-Costa HH, Oliveira DCG de, Zuardi AW, Zangrossi Junior H. Serotonin mediates the panicolytic-like effect of oxytocin in the dorsal periaqueductal gray [Internet]. Journal of Psychopharmacology. 2020 ; 34( 4): 383-390.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1177/0269881120907960
Artigo de periodico
Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors (2019)
Jesus, Carlos Henrique Alves; Redivo, Daiany Darlly Bello; Gasparin, Aléxia Thamara; Sotomaior, Bruna Bittencourt; Carvalho, Milene Cristina de ; Genaro, Karina ; Zuardi, Antônio Waldo ; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Zanoveli, Janaina Menezes; Cunha, Joice Maria da
Source: Brain Research. Unidade: FMRP
Subjects: DIABETES MELLITUS, NEUROPATIAS DIABÉTICAS, CANABINOIDES, RECEPTORES DE DROGA, SEROTONINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JESUS, Carlos Henrique Alves et al. Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors. Brain Research, v. 1715, p. 156-164, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.brainres.2019.03.014. Acesso em: 22 ago. 2024.
APA
Jesus, C. H. A., Redivo, D. D. B., Gasparin, A. T., Sotomaior, B. B., Carvalho, M. C. de, Genaro, K., et al. (2019). Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors. Brain Research, 1715, 156-164. doi:10.1016/j.brainres.2019.03.014
NLM
Jesus CHA, Redivo DDB, Gasparin AT, Sotomaior BB, Carvalho MC de, Genaro K, Zuardi AW, Hallak JEC, Crippa JA de S, Zanoveli JM, Cunha JM da. Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors [Internet]. Brain Research. 2019 ; 1715 156-164.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1016/j.brainres.2019.03.014
Vancouver
Jesus CHA, Redivo DDB, Gasparin AT, Sotomaior BB, Carvalho MC de, Genaro K, Zuardi AW, Hallak JEC, Crippa JA de S, Zanoveli JM, Cunha JM da. Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors [Internet]. Brain Research. 2019 ; 1715 156-164.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1016/j.brainres.2019.03.014
Artigo de periodico
Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms? (2019)
Crippa, José Alexandre de Souza ; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antônio Waldo ; Guimarães, Francisco Silveira ; Tumas, Vitor ; Santos, Rafael Guimarães dos
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FMRP
Subjects: DOENÇA DE PARKINSON, CANABINOIDES, SINTOMAS E PATOLOGIA GERAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms?. European Archives of Psychiatry and Clinical Neuroscience, v. 269, n. 1, p. 121-133, 2019Tradução . . Disponível em: https://doi.org/10.1007/s00406-019-00982-6. Acesso em: 22 ago. 2024.
APA
Crippa, J. A. de S., Hallak, J. E. C., Zuardi, A. W., Guimarães, F. S., Tumas, V., & Santos, R. G. dos. (2019). Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms? European Archives of Psychiatry and Clinical Neuroscience, 269( 1), 121-133. doi:10.1007/s00406-019-00982-6
NLM
Crippa JA de S, Hallak JEC, Zuardi AW, Guimarães FS, Tumas V, Santos RG dos. Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms? [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2019 ; 269( 1): 121-133.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1007/s00406-019-00982-6
Vancouver
Crippa JA de S, Hallak JEC, Zuardi AW, Guimarães FS, Tumas V, Santos RG dos. Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms? [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2019 ; 269( 1): 121-133.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1007/s00406-019-00982-6
Artigo de periodico
Modulation of the endocannabinoid and oxytocinergic systems as a potential treatment approach for social anxiety disorder (2019)
Dos Santos, Rafael Guimarães dos ; Osório, Flávia de Lima ; Martin-Santos, Rocio ; Zuardi, Antônio Waldo ; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza
Source: CNS Drugs. Unidade: FMRP
Subjects: TRANSTORNOS DA ANSIEDADE, ANSIEDADE SOCIAL, CANABINOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DOS SANTOS, Rafael Guimarães dos et al. Modulation of the endocannabinoid and oxytocinergic systems as a potential treatment approach for social anxiety disorder. CNS Drugs, v. 33, n. 10, p. 1031-1038, 2019Tradução . . Disponível em: https://doi.org/10.1007/s40263-019-00669-5. Acesso em: 22 ago. 2024.
APA
Dos Santos, R. G. dos, Osório, F. de L., Martin-Santos, R., Zuardi, A. W., Hallak, J. E. C., & Crippa, J. A. de S. (2019). Modulation of the endocannabinoid and oxytocinergic systems as a potential treatment approach for social anxiety disorder. CNS Drugs, 33( 10), 1031-1038. doi:10.1007/s40263-019-00669-5
NLM
Dos Santos RG dos, Osório F de L, Martin-Santos R, Zuardi AW, Hallak JEC, Crippa JA de S. Modulation of the endocannabinoid and oxytocinergic systems as a potential treatment approach for social anxiety disorder [Internet]. CNS Drugs. 2019 ; 33( 10): 1031-1038.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1007/s40263-019-00669-5
Vancouver
Dos Santos RG dos, Osório F de L, Martin-Santos R, Zuardi AW, Hallak JEC, Crippa JA de S. Modulation of the endocannabinoid and oxytocinergic systems as a potential treatment approach for social anxiety disorder [Internet]. CNS Drugs. 2019 ; 33( 10): 1031-1038.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1007/s40263-019-00669-5
Artigo de periodico
Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system (2018)
Schonhofen, Patrícia; Bristot, Ivi Juliana; Crippa, José Alexandre de Souza; Hallak, Jaime Eduardo Cecílio; Zuardi, Antônio Waldo; Parsons, Richard B.; Klamt, Fábio
Source: CNS Drugs. Unidade: FMRP
Subjects: CANNABIS, TERAPÊUTICA MÉDICA, SISTEMA NERVOSO CENTRAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHONHOFEN, Patrícia et al. Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system. CNS Drugs, v. 32, n. 8, p. 697-712, 2018Tradução . . Disponível em: https://doi.org/10.1007/s40263-018-0550-4. Acesso em: 22 ago. 2024.
APA
Schonhofen, P., Bristot, I. J., Crippa, J. A. de S., Hallak, J. E. C., Zuardi, A. W., Parsons, R. B., & Klamt, F. (2018). Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system. CNS Drugs, 32( 8), 697-712. doi:10.1007/s40263-018-0550-4
NLM
Schonhofen P, Bristot IJ, Crippa JA de S, Hallak JEC, Zuardi AW, Parsons RB, Klamt F. Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system [Internet]. CNS Drugs. 2018 ; 32( 8): 697-712.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1007/s40263-018-0550-4
Vancouver
Schonhofen P, Bristot IJ, Crippa JA de S, Hallak JEC, Zuardi AW, Parsons RB, Klamt F. Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system [Internet]. CNS Drugs. 2018 ; 32( 8): 697-712.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1007/s40263-018-0550-4
Artigo de periodico
Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age (2018)
Crippa, José Alexandre de Souza; Guimarães, Francisco Silveira; Campos, Alline Cristina de; Zuardi, Antônio Waldo
Source: Frontiers in Immunology. Unidade: FMRP
Subjects: CANABINOIDES, NEUROPSIQUIATRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age. Frontiers in Immunology, v. 9, 2018Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2018.02009. Acesso em: 22 ago. 2024.
APA
Crippa, J. A. de S., Guimarães, F. S., Campos, A. C. de, & Zuardi, A. W. (2018). Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age. Frontiers in Immunology, 9. doi:10.3389/fimmu.2018.02009
NLM
Crippa JA de S, Guimarães FS, Campos AC de, Zuardi AW. Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age [Internet]. Frontiers in Immunology. 2018 ; 9[citado 2024 ago. 22 ] Available from: https://doi.org/10.3389/fimmu.2018.02009
Vancouver
Crippa JA de S, Guimarães FS, Campos AC de, Zuardi AW. Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age [Internet]. Frontiers in Immunology. 2018 ; 9[citado 2024 ago. 22 ] Available from: https://doi.org/10.3389/fimmu.2018.02009
Artigo de periodico
Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol (2018)
Silva, Vanessa Kappel da; Freitas, Betânia Souza de; Dornelles, Victória Campos; Kist, Luiza Wilges; Bogo, Maurício Reis; Silva, Milena Carvalho; Streck, Emílio Luiz; Hallak, Jaime Eduardo Cecílio; Zuardi, Antônio Waldo; Crippa, José Alexandre de Souza; Schröder, Nadja
Source: Brain Research Bulletin. Unidade: FMRP
Subjects: CANABINOIDES, MITOCÔNDRIAS, DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Vanessa Kappel da et al. Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol. Brain Research Bulletin, v. 139, p. 1-8, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.brainresbull.2018.01.014. Acesso em: 22 ago. 2024.
APA
Silva, V. K. da, Freitas, B. S. de, Dornelles, V. C., Kist, L. W., Bogo, M. R., Silva, M. C., et al. (2018). Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol. Brain Research Bulletin, 139, 1-8. doi:10.1016/j.brainresbull.2018.01.014
NLM
Silva VK da, Freitas BS de, Dornelles VC, Kist LW, Bogo MR, Silva MC, Streck EL, Hallak JEC, Zuardi AW, Crippa JA de S, Schröder N. Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol [Internet]. Brain Research Bulletin. 2018 ; 139 1-8.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1016/j.brainresbull.2018.01.014
Vancouver
Silva VK da, Freitas BS de, Dornelles VC, Kist LW, Bogo MR, Silva MC, Streck EL, Hallak JEC, Zuardi AW, Crippa JA de S, Schröder N. Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol [Internet]. Brain Research Bulletin. 2018 ; 139 1-8.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1016/j.brainresbull.2018.01.014
Artigo de periodico
Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model (2018)
Callejas, G. H.; Figueira, R. L.; Gonçalves, F. L. L.; Volpe, F. A. P.; Zuardi, Antônio Waldo; Crippa, José Alexandre de Souza; Hallak, Jaime Eduardo Cecílio; Sbragia, Lourenço
Source: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Subjects: CANABINOIDES, DIAGNÓSTICO PRÉ-NATAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CALLEJAS, G. H. et al. Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model. Brazilian Journal of Medical and Biological Research, v. 51, n. 5, 2018Tradução . . Disponível em: https://doi.org/10.1590/1414-431x20177132. Acesso em: 22 ago. 2024.
APA
Callejas, G. H., Figueira, R. L., Gonçalves, F. L. L., Volpe, F. A. P., Zuardi, A. W., Crippa, J. A. de S., et al. (2018). Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model. Brazilian Journal of Medical and Biological Research, 51( 5). doi:10.1590/1414-431x20177132
NLM
Callejas GH, Figueira RL, Gonçalves FLL, Volpe FAP, Zuardi AW, Crippa JA de S, Hallak JEC, Sbragia L. Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model [Internet]. Brazilian Journal of Medical and Biological Research. 2018 ; 51( 5):[citado 2024 ago. 22 ] Available from: https://doi.org/10.1590/1414-431x20177132
Vancouver
Callejas GH, Figueira RL, Gonçalves FLL, Volpe FAP, Zuardi AW, Crippa JA de S, Hallak JEC, Sbragia L. Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model [Internet]. Brazilian Journal of Medical and Biological Research. 2018 ; 51( 5):[citado 2024 ago. 22 ] Available from: https://doi.org/10.1590/1414-431x20177132
Artigo de periodico
Correction: Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects (2016)
Breuer, Aviva; Haj, Christeene G.; Fogaça, Manoela V.; Gomes, Felipe V.; Silva, Nicole Rodrigues; Pedrazzi, João Francisco; Del Bel, Elaine Aparecida; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Zuardi, Antônio Waldo; Mechoulam, Raphael; Guimarães, Francisco Silveira
Source: PLOS ONE. Unidades: FORP, FMRP
Subjects: CANABINOIDES, FLUORAÇÃO, NEUROPSIQUIATRIA, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BREUER, Aviva et al. Correction: Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects. PLOS ONE, v. 11, n. 8, 2016Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0162087. Acesso em: 22 ago. 2024.
APA
Breuer, A., Haj, C. G., Fogaça, M. V., Gomes, F. V., Silva, N. R., Pedrazzi, J. F., et al. (2016). Correction: Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects. PLOS ONE, 11( 8). doi:10.1371/journal.pone.0162087
NLM
Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JEC, Crippa JA de S, Zuardi AW, Mechoulam R, Guimarães FS. Correction: Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects [Internet]. PLOS ONE. 2016 ; 11( 8):[citado 2024 ago. 22 ] Available from: https://doi.org/10.1371/journal.pone.0162087
Vancouver
Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JEC, Crippa JA de S, Zuardi AW, Mechoulam R, Guimarães FS. Correction: Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects [Internet]. PLOS ONE. 2016 ; 11( 8):[citado 2024 ago. 22 ] Available from: https://doi.org/10.1371/journal.pone.0162087

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration